江苏万略医药科技有限公司-江苏万略医药科技有限公司

新闻资讯
NEWS CENTER

参考文献

首页 >> 新闻资讯 >> 参考文献

新闻标题		发布时间
	Pharmacokinetics, Mass Balance, and Biotransformation of [ 14C]tinengotinib, A Novel Multi‑target Kinase Inhibitor, in Healthy Subjects	[2025-07-03]
	Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using 14C-radiolabelled techniques	[2025-07-03]
	Absorption, Metabolism and Excretion of Surufatinib in Rats and Humans	[2025-07-03]
	Study of the mass balance, biotransformation and safety of [14C]SHR8554, a novel μ-opioid receptor injection, in healthy Chinese subjects	[2025-07-03]
	Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a Novel ALK Inhibitor, in healthy subjects: a phase I human radiolabeled Mass balance study	[2025-07-03]
	Study of the mass balance, biotransformation, and safety of [14C]IBI351 in healthy Chinese subjects	[2025-07-03]
	Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects	[2025-07-03]
	The metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C] cetagliptin in healthy volunteers	[2025-07-03]
	Mass balance, metabolism, and pharmacokinetics of [14C] amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin’s lymphoma, in healthy Chinese volunteers	[2025-07-03]

首页 <上一页 1 下一页> 尾页共 1 页共 9 条信息

公司简介部门介绍研发服务新闻中心招贤纳士客户留言联系我们

媒体支持：

Copyright 2016 江苏万略医药科技有限公司版权所有

苏公网安备 32011102010112号

苏ICP备 16033444号-1